<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04178109</url>
  </required_header>
  <id_info>
    <org_study_id>17200</org_study_id>
    <nct_id>NCT04178109</nct_id>
  </id_info>
  <brief_title>Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.</brief_title>
  <official_title>EVALUATION OF ORAL USE OF DEXKETOPROFEN/TRAMADOL IN ACUTE POSTOPERATIVE PAIN IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT WITH A MINIMALLY INVASIVE ANTERIOR APPROACH (AMIS).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KAT General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KAT General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain is a global public health issue and represents the most common reason for both physician
      consultation and hospital admissions . When unrelieved or poorly controlled, it is associated
      with medical complications, poor patient satisfaction and increased risk of developing
      chronic pain. Dexketoprofen is a new NSAID treating acute postoperative pain and when it
      combined with tramadol may have a better effect. The purpose of this study is to evaluate the
      analgesic effect of the oral use of the combination of dexketoprofen/tramadole on the
      reduction of postoperative pain after total hip arthroplasty with minimal invasive anterior
      approach (AMIS).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2019</start_date>
  <completion_date type="Actual">November 20, 2019</completion_date>
  <primary_completion_date type="Actual">November 10, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score in 8hours</measure>
    <time_frame>8 hours</time_frame>
    <description>Pain score with the visualised analogue scale in 8hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score in 24hours</measure>
    <time_frame>24 hours</time_frame>
    <description>Pain score with the visualised analogue scale in 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score in 48 hours</measure>
    <time_frame>48 hours</time_frame>
    <description>Pain score with the visualised analogue scale in 48 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score in 72 hours</measure>
    <time_frame>72 hours</time_frame>
    <description>Pain score with the visualised analogue scale in 72 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total analgesic consumption</measure>
    <time_frame>24 houra</time_frame>
    <description>Total analgesic consumption as rescue analgesia the first 24 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>72 hours</time_frame>
    <description>All the side effects of the drug the first 72 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">226</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A was under spinal anesthesia with a 25G cutting edge needle with levobupivacaine 10-15mg and fentanyl 10μg.
Periarticular injection was done by the surgeon with a dilition of 100ml N/S 0,9% with 300mg ropivacaine and 0,5mg epinephrine.
Group A was given the oral combination dexketoprofen/tramadole (25mg/75mg) 2h after surgery every 8h for 72h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group B was under spinal anesthesia with a 25G cutting edge needle with levobupivacaine 10-15mg and fentanyl 10μg.
Periarticular injection was done by the surgeon with a dilition of 100ml N/S 0,9% with 300mg ropivacaine and 0,5mg epinephrine.
Group B received postoperative analgesia with intravenous tramadole 75mg and paracetamol 1g every 8h with the first dose beginning 2h after the end of the surgery. For 72h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexketoprofen/tramadol (27mg/75mg)</intervention_name>
    <description>Postoperatively patients in Group A received the oral combination dexketoprofen/tramadol for the treatment of acute postoperative pain the first 72h</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol hydrochloride</intervention_name>
    <description>Patients in group B received IV tramadol 75mg every 8h</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>Patients in group B received IV paracetamol 1g every 8h</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hydrochloride 7.5 MG/ML</intervention_name>
    <description>300mg ropivacaine as periarticular injection in a dilution of 100ml n/s 0,9% was done by the orthopedic surgeon in all patients</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine Hydrochloride</intervention_name>
    <description>10-15mg levobupivacaine was done subarachnoidal for spinal anesthesia</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral total hip arthroplasty with a direct anterior minimal invasive technique

          -  ASA score I or II

          -  signed written informed consent form

          -  3 days hospitalization

          -  45-80 years old

          -  primary Total hip arthroplasty

        Exclusion Criteria:

          -  allergy to any given drugs

          -  contraindications for spinal anesthesia

          -  active bleeding

          -  renal failure ( gfr&lt; 90ml/h)

          -  hepatic failure ( abnormal sgot,sgpt,γgt)

          -  heart failure

          -  history of gastrointestinal bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Elena Nikolakopoulou</name>
      <address>
        <city>Athens</city>
        <state>Kifissia</state>
        <zip>14571</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 24, 2019</study_first_submitted>
  <study_first_submitted_qc>November 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>November 24, 2019</last_update_submitted>
  <last_update_submitted_qc>November 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KAT General Hospital</investigator_affiliation>
    <investigator_full_name>Elena Nikolakopoulou</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

